Cargando…
GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis
As yet, very few vaccine candidates with activity in animals against Mycobacterium tuberculosis infection have been tested as therapeutic postexposure vaccines. We recently described two pools of mycobacterial proteins with this activity, and here we describe further studies in which four of these p...
Autores principales: | King, Thomas H., Shanley, Crystal A., Guo, Zhimin, Bellgrau, Donald, Rodell, Timothy, Furney, Synthia, Henao-Tamayo, Marcela, Orme, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717186/ https://www.ncbi.nlm.nih.gov/pubmed/29046306 http://dx.doi.org/10.1128/CVI.00245-17 |
Ejemplares similares
-
The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
por: Henao-Tamayo, Marcela, et al.
Publicado: (2015) -
Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission
por: Shanley, Crystal A., et al.
Publicado: (2018) -
Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis
por: Orme, Ian M., et al.
Publicado: (2018) -
Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial
por: Cohn, Allen, et al.
Publicado: (2018) -
Gr1(int)CD11b(+) Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection
por: Obregón-Henao, Andrés, et al.
Publicado: (2013)